"Our care team at the Dell Children's Blood & Cancer Center in Austin, Texas, listens to understand your questions and concerns and provide answers to your questions. Then we deliver a care plan with cancer-fighting infusion therapies, treatments and support programs. As part of Ascension Texas services at Dell Children's Medical Center, our pediatric medical oncologists and hematologists specialize in treating childhood cancers, including leukemia, lymphoma and myeloma. We’re dedicated to helping you defeat cancer."

During the past decade, Dell Children's Blood and Cancer Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dell Children's Blood and Cancer Center" #1 collaborator was "Beat NB Cancer Foundation" with 4 trials as a collaborator, "Dell, Inc." with 3 trials as a collaborator, "K C Pharmaceuticals Inc." with 3 trials as a collaborator, "Team Parker for Life" with 3 trials as a collaborator and "Children's Oncology Group (COG)" with 2 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Dell Children's Blood and Cancer Center" are "Neuroblastoma" (7 trials), "Medulloblastoma" (4 trials), "Rhabdomyosarcoma" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials) and "Brain Tumors" (1 trials). Many other conditions were trialed in "Dell Children's Blood and Cancer Center" in a lesser frequency.

Most popular intervention types in "Dell Children's Blood and Cancer Center" are "Drug" (8 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "DFMO" (2 trials), "Antibody Drug Conjugate Chemotherapeutic" (1 trials), "Buprenorphine transdermal system" (1 trials), "Ceritinib" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dell Children's Blood and Cancer Center" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Dell Children's Blood and Cancer Center". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dell Children's Blood and Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dell Children's Blood and Cancer Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".